Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05561595 · ClinicalTrials.gov registry record · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
A NA study of Obesity and Cancer, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 195
- Enrollment target
- 1
- Study location
NCT05561595: Recruiting NA study of Obesity and Cancer, sponsored by University of Florida.
NCT05561595 is a NA study of Obesity and Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 195 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05561595, a NA study of Obesity and Cancer, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
- 1
- Study location
Study Summary
Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.
Primary Outcome
Estimated mean change score for the total scale (primary outcome) and three subscales (Perceived and Anticipated Stigma, Stereotype Application and Self-Devaluation, and Stigma Resistance); scale scores are averaged and range from 1-7, with higher scores indicating greater internalized health-related stigma.
Conditions Studied
Interventions
- BEHAVIORAL Healing HEARTS
- BEHAVIORAL Peer Support
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT05561595 shows while recruiting
NCT05561595 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower).
The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Healing HEARTS is the first listed.
NCT05561595 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05561595 about?
NCT05561595 is a clinical study titled "Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma". Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and...
What is the current status of trial NCT05561595?
This trial is currently recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2024-10-03. Estimated completion is 2027-03-31.
What conditions does trial NCT05561595 study?
This clinical trial studies the following conditions: Obesity, Cancer, Diabetes, HIV, Chronic Pain.
What interventions are being tested in trial NCT05561595?
The interventions under investigation include: Healing HEARTS (BEHAVIORAL), Peer Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05561595?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05561595 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05561595's enrollment target sits among peer trials
195 327th of 1053 higher than 725 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT06008795 · 195 participants · Phase 2
BLOCK-SAH - PPF-Block for Post-SAH Headache
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI